Brocks Ulrike, Ziegler Martin, Lange Clemens, Altay Lebriz, Pauleikhoff Laurenz
Klinik für Augenheilkunde, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.
Augenzentrum am St. Franziskus Hospital, Münster, Deutschland.
Ophthalmologie. 2025 Mar;122(3):196-200. doi: 10.1007/s00347-025-02197-8. Epub 2025 Feb 10.
The occurrence of secondary choroidal neovascularization (CNV) is a complication in patients with chronic central serous chorioretinopathy. The diagnosis is made using multimodal imaging. The treatment usually includes intravitreal anti-vascular endothelial growth factor (VEGF) injections. A combination with photodynamic therapy can be useful; however, the response to anti-VEGF treatment is significantly reduced compared to other indications for CNV, so that an irreversible decrease of visual acuity often remains.
继发性脉络膜新生血管（CNV）的发生是慢性中心性浆液性脉络膜视网膜病变患者的一种并发症。诊断采用多模式成像。治疗通常包括玻璃体内注射抗血管内皮生长因子（VEGF）。联合光动力疗法可能有用；然而，与CNV的其他适应症相比，抗VEGF治疗的反应明显降低，因此视力往往会出现不可逆的下降。
